Five things for pharma marketers to know: Tuesday, February 28, 2017

J&J discloses list prices for its drugs; Kite's CAR-T therapy meets study goals; healthcare providers seek to engage patients in decisionmaking

What uncertainty? 72% of health marketers say 2017 budgets are up

This according to the 172 healthcare marketing executives who participated in the 2017 MM&M/Guidemark Health Healthcare Marketers Trend Report.

Havas Health, Vencore form JV focused on rare diseases

Havas Health, Vencore form JV focused on rare diseases

The joint venture pairs a communication powerhouse with a provider of defense-department-grade predictive analytics.

Cigna partners with Microsoft HoloLens on biometric game

Cigna partners with Microsoft HoloLens on biometric game

The health insurer partnered with Microsoft to use VR and AR technology to gather biometric data.

Publicis Health formalizes new name, promotes 3 execs

Publicis Health formalizes new name, promotes 3 execs

The network was previously called Publicis Healthcare Communications Group.

Five things for pharma marketers to know: Monday, February 27, 2017

Five things for pharma marketers to know: Monday, February 27, 2017

Pfizer receives subpoena over patient assistance programs; drugmakers raise prices less this January than last; lawmakers have new plan to repeal ACA

Guidemark Health's Sophy Regelous on why small budgets are increasing

Guidemark Health's Sophy Regelous on why small budgets are increasing

Guidemark Health COO Sophy Regelous shares her perspective on the 2017 MM&M/Guidemark Health Healthcare Marketers Report.

Five things for pharma marketers to know: Friday, February 24, 2017

Five things for pharma marketers to know: Friday, February 24, 2017

PBMs' use of "clawbacks" prompt lawsuits; Merck's experimental antiviral drug prevents infection; EMA recommends Novartis' lung-cancer combo drug

MAHF honors Abbate and Lazur, Future Famers

MAHF honors Abbate and Lazur, Future Famers

The Medical Advertising Hall of Fame recognized dozens of industry leaders and rising agency executives.

Five things for pharma marketers to know: Thursday, February 23, 2017

Five things for pharma marketers to know: Thursday, February 23, 2017

Harvard Pilgrim signs pay-for-performance deals with Lilly and Amgen; new advocacy group wants lower drug prices; Zykadia gets priority review

Almost one-third of programmatic ads violate IAB guidelines, study finds

Almost one-third of programmatic ads violate IAB guidelines, study finds

The report identifies four major issues of the 28% that were found to abuse IAB's standards.

Five things for pharma marketers to know: Wednesday, February 22, 2017

Five things for pharma marketers to know: Wednesday, February 22, 2017

Audit says MD Anderson Cancer Center mismanaged Watson partnership; Icahn takes stake in BMS; Sarepta sells priority review voucher to Gilead

Deloitte taps Havas Lynx's Mickelberg as MD

Deloitte taps Havas Lynx's Mickelberg as MD

Dennis Urbaniak has also been named chief digital officer at Havas Lynx.

Read the complete January 2017 digital edition

Read the complete January 2017 digital edition

Here you'll find everything you need to know from MM&M's January 2017 issue, including our health-tech preview, a deep dive into data science, and report on digital innovation from Japanese drugmakers.

Five things for pharma marketers to know: Tuesday, February 21, 2017

Five things for pharma marketers to know: Tuesday, February 21, 2017

Pharma industry remains focused on Alzheimer's, despite setbacks; few new diabetes drugs in development; the FDA issues complete response letter to Trevena

How VAYA Pharma used Facebook ads for its ADHD campaign

How VAYA Pharma used Facebook ads for its ADHD campaign

The campaign would require a two-fold approach: Facebook link ads and Facebook Audience Network.

WebMD considers sale or merger

WebMD considers sale or merger

Drugmakers are becoming much more cautious with their budgets, WebMD executives said.

Five things for pharma marketers to know: Friday, February 17, 2017

Five things for pharma marketers to know: Friday, February 17, 2017

Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March

Roche gears up to enter loaded hemophilia A drug market

Roche gears up to enter loaded hemophilia A drug market

A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn't stopped contenders such as Roche's emicizumab.

Five things for pharma marketers to know: Thursday, February 16, 2017

Five things for pharma marketers to know: Thursday, February 16, 2017

The FDA approves Valeant's psoriasis drug; PhRMA to review its membership criteria; Lions Health announces pharma and health and wellness jury presidents

Agency Spotlight

Featured Listings

W2O Group

W2O Group

W2O Group, founded in 2001 by Jim Weiss, a ...

OPINION

Why President Trump Won't Overhaul the FDA

Newsletters